Beta-arrestin 2 is required for complement C1q expression in macrophages and constrains factor-independent survival

Molecular Immunology

Volumn 47, Issue 2-3, 2009, Pages 340-347

  Lattin, Jane E ^a   Greenwood, Kathryn P ^a   Daly, Norelle L ^a   Kelly, Gregory ^a   Zidar, David A ^b   Clark, Richard J ^a   Thomas, Walter G ^a   Kellie, Stuart ^a   Craik, David J ^a   Hume, David A ^c   Sweet, Matthew J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Complement; Inflammation; Monocyte macrophage; Signal transduction; Systemic lupus erythematosus

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1QA; COMPLEMENT COMPONENT C1QB; COMPLEMENT COMPONENT C1QC; COMPLEMENTARY DNA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; RNA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW; CELL STRAIN HEK293; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MACROPHAGE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; ARRESTINS; BONE MARROW CELLS; CELL LINE; CELL SURVIVAL; COMPLEMENT C1Q; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PEPTIDES; PHENOTYPE;

MUS;

EID: 70450223708     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.09.012     Document Type: Article

References (53)

1. Ahn S., Wei H., Garrison T.R., and Lefkowitz R.J. Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2. J. Biol. Chem. 279 (2004) 7807-7811
2. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
3. Attramadal H., Arriza J.L., Aoki C., Dawson T.M., Codina J., Kwatra M.M., Snyder S.H., Caron M.G., and Lefkowitz R.J. Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J. Biol. Chem. 267 (1992) 17882-17890
4. Azzi M., Charest P.G., Angers S., Rousseau G., Kohout T., Bouvier M., and Pineyro G. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 11406-11411
5. Bohn L.M., Lefkowitz R.J., Gainetdinov R.R., Peppel K., Caron M.G., and Lin F.T. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286 (1999) 2495-2498
6. Bonifer C., Hoogenkamp M., Krysinska H., and Tagoh H. How transcription factors program chromatin--lessons from studies of the regulation of myeloid-specific genes. Semin. Immunol. 20 (2008) 257-263
7. Carroll M.C. The complement system in regulation of adaptive immunity. Nat. Immunol. 5 (2004) 981-986
8. Clark R.J., Daly N.L., and Craik D.J. Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design. Biochem. J. 394 (2006) 85-93
9. Clas F., Euteneuer B., Stemmer F., and Loos M. Interaction of fluid phase C1/C1q and macrophage membrane-associated C1q with gram-negative bacteria. Behring Inst. Mitt. (1989) 236-254
10. Comalada M., Xaus J., Sanchez E., Valledor A.F., and Celada A. Macrophage colony-stimulating factor-, granulocyte-macrophage colony-stimulating factor-, or IL-3-dependent survival of macrophages, but not proliferation, requires the expression of p21(Waf1) through the phosphatidylinositol 3-kinase/Akt pathway. Eur. J. Immunol. 34 (2004) 2257-2267
11. Conner D.A., Mathier M.A., Mortensen R.M., Christe M., Vatner S.F., Seidman C.E., and Seidman J.G. Beta-arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation. Circ. Res. 81 (1997) 1021-1026
12. DeFea K.A., Zalevsky J., Thoma M.S., Dery O., Mullins R.D., and Bunnett N.W. Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J. Cell. Biol. 148 (2000) 1267-1281
13. DeWire S.M., Ahn S., Lefkowitz R.J., and Shenoy S.K. Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69 (2007) 483-510
14. Fan H., Luttrell L.M., Tempel G.E., Senn J.J., Halushka P.V., and Cook J.A. Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. Mol. Immunol. 44 (2007) 3092-3099
15. Figueroa J.E., and Densen P. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4 (1991) 359-395
16. Fowles L.F., Martin M.L., Nelsen L., Stacey K.J., Redd D., Clark Y.M., Nagamine Y., McMahon M., Hume D.A., and Ostrowski M.C. Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling. Mol. Cell. Biol. 18 (1998) 5148-5156
17. Fraser D.A., Bohlson S.S., Jasinskiene N., Rawal N., Palmarini G., Ruiz S., Rochford R., and Tenner A.J. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J. Leukoc. Biol. 80 (2006) 107-116
18. Fujita T., Matsushita M., and Endo Y. The lectin-complement pathway-its role in innate immunity and evolution. Immunol. Rev. 198 (2004) 185-202
19. Gao H., Sun Y., Wu Y., Luan B., Wang Y., Qu B., and Pei G. Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol. Cell. 14 (2004) 303-317
20. Ge L., Ly Y., Hollenberg M., and DeFea K. A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. J. Biol. Chem. 278 (2003) 34418-34426
21. Hamilton J.A. CSF-1 signal transduction. J. Leukoc. Biol. 62 (1997) 145-155
22. Herce H.D., and Garcia A.E. Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 20805-20810
23. Himes S.R., Cronau S., Mulford C., and Hume D.A. The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages. Oncogene 24 (2005) 5278-5286
24. Himes S.R., Sester D.P., Ravasi T., Cronau S.L., Sasmono T., and Hume D.A. The JNK are important for development and survival of macrophages. J. Immunol. 176 (2006) 2219-2228
25. Jaworowski A., Wilson N.J., Christy E., Byrne R., and Hamilton J.A. Roles of the mitogen-activated protein kinase family in macrophage responses to colony stimulating factor-1 addition and withdrawal. J. Biol. Chem. 274 (1999) 15127-15133
26. Kishore U., and Reid K.B. C1q: structure, function, and receptors. Immunopharmacology 49 (2000) 159-170
27. Kodzius R., Kojima M., Nishiyori H., Nakamura M., Fukuda S., Tagami M., Sasaki D., Imamura K., Kai C., Harbers M., Hayashizaki Y., and Carninci P. CAGE: cap analysis of gene expression. Nat. Methods 3 (2006) 211-222
28. Lattin J.E., Schroder K., Su A.I., Walker J.R., Zhang J., Wiltshire T., Saijo K., Glass C.K., Hume D.A., Kellie S., and Sweet M.J. Expression analysis of G protein-coupled receptors in mouse macrophages. Immunome Res. 4 (2008) 5
29. Luttrell L.M., Roudabush F.L., Choy E.W., Miller W.E., Field M.E., Pierce K.L., and Lefkowitz R.J. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 2449-2454
30. Manderson A.P., Botto M., and Walport M.J. The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 22 (2004) 431-456
31. McDonald P.H., Chow C.W., Miller W.E., Laporte S.A., Field M.E., Lin F.T., Davis R.J., and Lefkowitz R.J. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290 (2000) 1574-1577
32. Miller W.E., McDonald P.H., Cai S.F., Field M.E., Davis R.J., and Lefkowitz R.J. Identification of a motif in the carboxyl terminus of beta-arrestin2 responsible for activation of JNK3. J. Biol. Chem. 276 (2001) 27770-27777
33. Moore C.A., Milano S.K., and Benovic J.L. Regulation of receptor trafficking by GRKs and arrestins. Annu. Rev. Physiol. 69 (2007) 451-482
34. Moosig F., Damm F., Knorr-Spahr A., Ritgen M., Zeuner R.A., Kneba M., Ernst M., and Schroder J.O. Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 146 (2006) 409-416
35. Morgan B.P., Marchbank K.J., Longhi M.P., Harris C.L., and Gallimore A.M. Complement: central to innate immunity and bridging to adaptive responses. Immunol. Lett. 97 (2005) 171-179
36. Nath S.K., Kelly J.A., Namjou B., Lam T., Bruner G.R., Scofield R.H., Aston C.E., and Harley J.B. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am. J. Hum. Genet. 69 (2001) 1401-1406
37. O'Neill L.A. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Curr. Top. Microbiol. Immunol. 270 (2002) 47-61
38. Ogden C.A., deCathelineau A., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.A., and Henson P.M. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194 (2001) 781-795
39. Paidassi H., Tacnet-Delorme P., Garlatti V., Darnault C., Ghebrehiwet B., Gaboriaud C., Arlaud G.J., and Frachet P. C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition. J. Immunol. 180 (2008) 2329-2338
40. Parameswaran N., Pao C.S., Leonhard K.S., Kang D.S., Kratz M., Ley S.C., and Benovic J.L. Arrestin-2 and G protein-coupled receptor kinase 5 interact with NFkappa B1 p105 and negatively regulate lipopolysaccharide-stimulated ERK1/2 activation in macrophages. J. Biol. Chem. (2006)
41. Sanchez-Tillo E., Comalada M., Xaus J., Farrera C., Valledor A.F., Caelles C., Lloberas J., and Celada A. JNK1 Is required for the induction of Mkp1 expression in macrophages during proliferation and lipopolysaccharide-dependent activation. J. Biol. Chem. 282 (2007) 12566-12573
42. Schnolzer M., Alewood P., Jones A., Alewood D., and Kent S.B. In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. Int. J. Pept. Prot. Res. 40 (1992) 180-193
43. Sester D.P., Beasley S.J., Sweet M.J., Fowles L.F., Cronau S.L., Stacey K.J., and Hume D.A. Bacterial/CpG DNA down-modulates colony stimulating factor-1 receptor surface expression on murine bone marrow-derived macrophages with concomitant growth arrest and factor-independent survival. J. Immunol. 163 (1999) 6541-6550
44. Sester D.P., Brion K., Trieu A., Goodridge H.S., Roberts T.L., Dunn J., Hume D.A., Stacey K.J., and Sweet M.J. CpG DNA activates survival in murine macrophages through TLR9 and the phosphatidylinositol 3-kinase-Akt pathway. J. Immunol. 177 (2006) 4473-4480
45. Sun Y., Cheng Z., Ma L., and Pei G. Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J. Biol. Chem. 277 (2002) 49212-49219
46. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., Savill J.S., Henson P.M., Botto M., and Walport M.J. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192 (2000) 359-366
47. Terheyden P., Loos M., Storkel S., and Kaul M. Human macrophages simultaneously express membrane-C1q and Fc-receptors for IgG. Immunol. Lett. 101 (2005) 202-209
48. Trouw L.A., Blom A.M., and Gasque P. Role of complement and complement regulators in the removal of apoptotic cells. Mol. Immunol. 45 (2008) 1199-1207
49. Valledor A.F., Comalada M., Xaus J., and Celada A. The differential time-course of extracellular-regulated kinase activity correlates with the macrophage response toward proliferation or activation. J. Biol. Chem. 275 (2000) 7403-7409
50. Wang Y., Tang Y., Teng L., Wu Y., Zhao X., and Pei G. Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 7 (2006) 139-147
51. Warren J., Mastroeni P., Dougan G., Noursadeghi M., Cohen J., Walport M.J., and Botto M. Increased susceptibility of C1q-deficient mice to Salmonella enterica serovar Typhimurium infection. Infect. Immun. 70 (2002) 551-557
52. Witherow D.S., Garrison T.R., Miller W.E., and Lefkowitz R.J. beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 8603-8607
53. Yamada M., Oritani K., Kaisho T., Ishikawa J., Yoshida H., Takahashi I., Kawamoto S., Ishida N., Ujiie H., Masaie H., Botto M., Tomiyama Y., and Matsuzawa Y. Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. Eur. J. Immunol. 34 (2004) 221-230